Nintedanib
Ofev (nintedanib) is a prescription oral capsule medication manufactured by Boehringer Ingelheim Pharmaceuticals, Inc. It comes in 100mg and 150mg strengths and acts as a kinase inhibitor. Approved under NDA205832, it has been on the market since 2014. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Ofev (nintedanib) is a prescription oral capsule medication manufactured by Boehringer Ingelheim Pharmaceuticals, Inc. It comes in 100mg and 150mg strengths and acts as a kinase inhibitor. Approved under NDA205832, it has been on the market since 2014. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Nintedanib",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Nintedanib — ANDA 205832 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205832"
}
]
|
| identifier | ANDA205832 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"health-care",
"medications",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Nintedanib |
